Pump failure death and sudden cardiac death in patients with cardiac dysfunction: A search for prognostic predictive factors-A long-term follow-up study

Journal of Cardiology

Volumn 55, Issue 1, 2010, Pages 55-64

  Usuku, Hiroki ^a   Nakayama, Masafumi ^a   Sumida, Hitoshi ^a   Yamamuro, Megumi ^a   Izumiya, Yasuhiro ^a   Suzuki, Satoru ^a   Kusuhara, Kenichi ^a   Ueno, Hirofumi ^a   Sugiyama, Seigo ^a   Yoshimura, Michihiro ^b   Ogawa, Hisao ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

B type natriuretic peptide; Estimated glomerular filtration rate; Heart failure; Sudden cardiac death

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; NITRATE; SPIRONOLACTONE; STATIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EQUIPMENT; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART ASSIST DEVICE; HEART DISEASE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SUDDEN DEATH;

AGED; CAUSE OF DEATH; DEATH, SUDDEN, CARDIAC; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE; HUMANS; MALE; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; ROC CURVE; SURVIVAL ANALYSIS;

EID: 72449151205     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.08.005     Document Type: Article

References (33)

1. Jessup M., and Brozena S. Heart failure. N Engl J Med 348 (2003) 2007-2018
2. Yasue H., Obata K., Okumura K., Kurose M., Ogawa H., Matsuyama K., Jougasaki M., Saito Y., Nakao K., and Imura H. Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy. J Clin Invest 83 (1989) 46-51
3. Yasue H., Yoshimura M., Sumida H., Kikuta K., Kugiyama K., Jougasaki M., Ogawa H., Okumura K., Mukoyama M., and Nakao K. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90 (1994) 195-203
4. Mukoyama M., Nakao K., Hosoda K., Suga S., Saito Y., Ogawa Y., Shirakami G., Jougasaki M., Obata K., Yasue H., Kambayashi Y., Inouye K., and Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87 (1991) 1402-1412
5. Bruneau B.G., Piazza L.A., and de Bold A.J. BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. Am J Physiol 273 6 Pt 2 (1997) H2678-H2686
6. Harada E., Nakagawa O., Yoshimura M., Harada M., Nakagawa M., Mizuno Y., Shimasaki Y., Nakayama M., Yasue H., Kuwahara K., Saito Y., and Nakao K. Effect of interleukin-1 beta on cardiac hypertrophy and production of natriuretic peptides in rat cardiocyte culture. J Mol Cell Cardiol 31 (1999) 1997-2006
7. Kuwahara K., Saito Y., Harada M., Ishikawa M., Ogawa E., Miyamoto Y., Hamanaka I., Kamitani S., Kajiyama N., Takahashi N., Nakagawa O., Masuda I., and Nakao K. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro. Circulation 100 (1999) 1116-1124
8. Nakaoka Y., Nishida K., Fujio Y., Izumi M., Terai K., Oshima Y., Sugiyama S., Matsuda S., Koyasu S., Yamauchi-Takihara K., Hirano T., Kawase I., and Hirota H. Activation of gp130 transduces hypertrophic signal through interaction of scaffolding/docking protein Gab1 with tyrosine phosphatase SHP2 in cardiomyocytes. Circ Res 93 (2003) 221-229
9. Hare J.M. Oxidative stress and apoptosis in heart failure progression. Circ Res 89 (2001) 198-200
10. Morita E., Yasue H., Yoshimura M., Ogawa H., Jougasaki M., Matsumura T., Mukoyama M., and Nakao K. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88 (1993) 82-91
11. Sumida H., Yasue H., Yoshimura M., Okumura K., Ogawa H., Kugiyama K., Matsuyama K., Kikuta K., Morita E., and Nakao K. Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction. J Am Coll Cardiol 25 (1995) 1105-1110
12. Suzuki S., Yoshimura M., Nakayama M., Mizuno Y., Harada E., Ito T., Nakamura S., Abe K., Yamamuro M., Sakamoto T., Saito Y., Nakao K., Yasue H., and Ogawa H. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation 110 (2004) 1387-1391
13. Maeda K., Tsutamoto T., Wada A., Mabuchi N., Hayashi M., Tsutsui T., Ohnishi M., Sawaki M., Fujii M., Matsumoto T., and Kinoshita M. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 36 (2000) 1587-1593
14. Sudoh T., Kangawa K., Minamino N., and Matsuo H. A new natriuretic peptide in porcine brain. Nature 332 (1988) 78-81
15. Ezekowitz J.A., McAlister F.A., and Armstrong P.W. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 107 (2003) 223-225
16. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
17. Cleland J.G., Dargie H.J., and Ford I. Mortality in heart failure: clinical variables of prognostic value. Br Heart J 58 (1987) 572-582
18. Kenchaiah S., Pocock S.J., Wang D., Finn P.V., Zornoff L.A., Skali H., Pfeffer M.A., Yusuf S., Swedberg K., Michelson E.L., Granger C.B., McMurray J.J., Solomon S.D., and CHARM Investigators. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Circulation 116 (2007) 627-636
19. Yasue H., Yoshimura M., Jougasaki M., Itoh H., Suga S., Ogawa Y., and Nakao K. Plasma levels of brain natriuretic peptide in normal subjects and patients with chronic congestive heart failure: measurement by immunoradiometric assay (IRMA). Horm Clin 41 (1993) 397-403
20. Imai E., Horio M., Nitta K., Yamagata K., Iseki K., Tsukamoto Y., Ito S., Makino H., Hishida A., and Matsuo S. Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. Am J Kidney Dis 50 (2007) 927-937
21. Richards A.M., Nicholls M.G., Espiner E.A., Lainchbury J.G., Troughton R.W., Elliott J., Frampton C., Turner J., Crozier I.G., and Yandle T.G. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107 (2003) 2786-2792
22. Matsuo K., Inoue T., and Node K. Estimated glomerular filtration rate as a predictor of secondary outcomes in Japanese patients with coronary artery disease. J Cardiol 53 (2009) 232-239
23. Mall G., Huther W., Schneider J., Lundin P., and Ritz E. Diffuse intermyocardiocytic fibrosis in uraemic patients. Nephrol Dial Transplant 5 (1990) 39-44
24. Levin A., Singer J., Thompson C.R., Ross H., and Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am J Kidney Dis 27 (1996) 347-354
25. Tun A., Khan I.A., Wattanasauwan N., Win M.T., Hussain A., Hla T.A., Cherukuri V.L., Vasavada B.C., and Sacchi T.J. Increased regional and transmyocardial dispersion of ventricular repolarization in end-stage renal disease. Can J Cardiol 15 (1999) 53-56
26. Morales M.A., Gremigni C., Dattolo P., Piacenti M., Cerrai T., Fazi A., Pelosi G., Vergassola R., and Maggiore Q. Signal-averaged ECG abnormalities in haemodialysis patients. Role of dialysis. Nephrol Dial Transplant 13 (1998) 668-673
27. Goldenberg I., Moss A.J., McNitt S., Zareba W., Andrews M.L., Hall W.J., Greenberg H., Case R.B., and Multicenter Automatic Defibrillator Implantation Trial-II Investigators. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 98 (2006) 485-490
28. Hama N., Itoh H., Shirakami G., Nakagawa O., Suga S., Ogawa Y., Masuda I., Nakanishi K., Yoshimasa T., Hashimoto Y., Yamaguchi M., Hori R., Yasue H., and Nakao K. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation 92 (1995) 1558-1564
29. Michels V.V., Moll P.P., Miller F.A., Tajik A.J., Chu J.S., Driscoll D.J., Burnett J.C., Rodeheffer R.J., Chesebro J.H., and Tazelaar H.D. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 326 (1992) 77-82
30. Muntoni F., Cau M., Ganau A., Congiu R., Arvedi G., Mateddu A., Marrosu M.G., Cianchetti C., Realdi G., Cao A., and Melis M.A. Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 329 (1993) 921-925
31. Kamisago M., Sharma S.D., DePalma S.R., Solomon S., Sharma P., McDonough B., Smoot L., Mullen M.P., Woolf P.K., Wigle E.D., Seidman J.G., and Seidman C.E. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 343 (2000) 1688-1696
32. Fatkin D., MacRae C., Sasaki T., Wolff M.R., Porcu M., Frenneaux M., Atherton J., Vidaillet Jr. H.J., Spudich S., De Girolami U., Seidman J.G., Seidman C., Muntoni F., Müehle G., Johnson W., et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 341 (1999) 1715-1724
33. D'Adamo P., Fassone L., Gedeon A., Janssen E.A., Bione S., Bolhuis P.A., Barth P.G., Wilson M., Haan E., Orstavik K.H., Patton M.A., Green A.J., Zammarchi E., Donati M.A., and Toniolo D. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet 61 (1997) 862-867